Vanda Pharmaceuticals
VNDA
#7807
Rank
โ‚น30.87 B
Marketcap
โ‚น522.32
Share price
-5.57%
Change (1 day)
36.26%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚น10.47 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.21 Billion. In 2024 the company made an earning of -โ‚น3.69 Billion a decrease over its 2023 earnings that were of -โ‚น1.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.47 Billion183.91%
2024 -โ‚น3.69 Billion191.43%
2023 -โ‚น1.27 Billion-320.45%
2022 โ‚น0.57 B-84.99%
2021 โ‚น3.82 B54.8%
2020 โ‚น2.47 B19.42%
2019 โ‚น2.06 B4.93%
2018 โ‚น1.97 B-228.6%
2017 -โ‚น1.54 Billion-8.98%
2016 -โ‚น1.69 Billion-53.79%
2015 -โ‚น3.65 Billion-30.18%
2014 -โ‚น5.22 Billion173.08%
2013 -โ‚น1.92 Billion-25.33%
2012 -โ‚น2.56 Billion163.61%
2011 -โ‚น0.98 Billion-221.15%
2010 โ‚น0.80 B-124.53%
2009 -โ‚น3.27 Billion-29.44%
2008 -โ‚น4.64 Billion-36.2%
2007 -โ‚น7.26 Billion21.81%
2006 -โ‚น5.96 Billion170.55%
2005 -โ‚น2.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.937 T-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.482 T-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น1.074 T-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.040 T-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.093 T-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น728.44 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚น0.26 Billion-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA